Editorials and Conflicts of Interest

In the August 29 issue of the Journal, an Original Article by Abenhaim et al., entitled “Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension” dealt with the increased risk of primary pulmonary hypertension in subjects taking antiobesity drugs.

Abstract

In the August 29 issue of the Journal, we published an Original Article by Abenhaim et al., entitled “Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension.”1 It dealt with the increased risk of primary pulmonary hypertension in subjects taking antiobesity drugs. In the same issue was a solicited editorial by Dr. JoAnn Manson and Dr. Gerald Faich, entitled “Pharmacotherapy for Obesity — Do the Benefits Outweigh the Risks?”2 As is the usual practice of the Journal, the editors asked the editorialists to put the study results into perspective for our readers. What we did not appreciate until it was . . .